key: cord-0889457-lwchtzmr
authors: Marinari, Giuseppe M.; Anselmino, Marco; Tascini, Carlo; Bernante, Paolo; Foletto, Mirto; Gentileschi, Paolo; Morino, Mario; Olmi, Stefano; Toppino, Mauro; Silecchia, Gianfranco
title: BARIATRIC AND METABOLIC SURGERY DURING COVID-19 OUTBREAK PHASE-2 IN ITALY: WHY, WHEN AND HOW TO RESTART
date: 2020-06-24
journal: Surg Obes Relat Dis
DOI: 10.1016/j.soard.2020.06.025
sha: 2af89534d7366985651e7dc1fe92ad04c08efcfd
doc_id: 889457
cord_uid: lwchtzmr

In Italy elective bariatric and metabolic surgery was cancelled on February 21,2020 at the beginning of the so-called phase 1 of the SARS-CoV-2 outbreak. Gradually it was restarted on May 4,2020 at the beginning of the so-called phase 2, when epidemiological data showed containment of the infection. Before the outbreak in eight high-volume bariatric centers 840 patients were surgically treated developing a Covid-19 infection, during phase 1, in only 5 cases (0.6%) without mortality. The post-operative complication rate was similar when compared to the 836 subjects submitted to bariatric surgery the year before. Since the high prevalence of infection in subjects with BMI > 30, it was argued that early intervention on obesity during phase 2 could help to minimize the effects of the disease in the event of a possible reversion to a SARS-CoV-2 outbreak phase 1. At the same time a prospective observational study from July 1 till the WHO declaration of the end of the pandemic has started in the eight high volume centers to monitor the post-operative outcome and its effect on SARS-CoV-2 infection.

Since its first isolation in Wuhan, China in December 2019, the novel Coronavirus 2

[SARS-CoV-2] responsible for the COVID-19, has become, in just a few months a pandemic. In Italy the first person-to-person transmission was reported on February 21 st , 2020, in Lombardia 5 region, causing so far one of the most extensive outbreaks in Europe. As of May 4 th , 2020, the total number of cases in Italy was 211,938, with 29,079 deaths and the estimated percentage of infected persons was 4,76% (4,28%-5,37%), that means almost 5.000.000 people [1, 2] . The near totality of elective non-oncologic procedures has been postponed by the end of February to increase capacity for in-patient beds and acute care [3] . 10 The elderly, especially those with a higher rate of comorbidities, were the most severely affected population [4] . It seems that the increased prevalence of obesity in older adults in Italy compared to Chinese population may account for the differences in mortality between the two countries. Thus, the rising prevalence of obesity in the US and prior experience of the impact of obesity on mortality from H1N1 flu should increase the sensitivity of clinicians caring for patients 15 with obesity and COVID-19 for the need for aggressive treatment [5] .

However, epidemiological studies conducted up to now have indicated obesity as severe comorbidity in subjects with age < 60 years. Young people with obesity have required intensive admission more often than normal-weight people with related higher mortality. In New York out of 3,615 subjects with SARS-CoV-2 positive swab between March 4 th and April 4 th , 21% had BMI 30-20 34 and 16% had BMI > 35. Robust data show a link between the BMI and the need for hospitalization and ICU admission in positive patients younger than 60 years [6] . A French study on 124 patients in ICU reports that obesity and morbid obesity affected 47.6% and 28.2% of COVID-19 cases respectively. [7] . The data from previous outbreaks, attributable to different viral agents, also shows a correlation between obesity and the severity of the clinical manifestation of viral disease [8, 9] .

The largest European prospective observational cohort study with rapid data gathering and 30 near real-time analysis, using a pre-approved questionnaire adopted by the WHO carried out in 166 UK hospitals between February 6 th and April 18 th , 2020 and involving 16,749 people with COVID-19, reported that obesity was associated with a higher probability of mortality [10] .

In a prospective, observational cohort of critically ill patients with confirmed SARS-CoV-2 infection admitted to ICU in Brescia (Lombardia, Italy) between March 2 nd and March 13 th , 2020 35 obesity was present in 31% of patients, with an additional 58% being overweight [11] High-volume Italian bariatric center network data Throughout the months of January and February 2020, no special protocol was adopted to contain the infection (period immediately before the lockdown).

The primary aim of the present multicenter retrospective report was to evaluate the impact of Similarly oncological and emergency patients operated in Northern Italy during the peak of 60 the outbreak on March and April, did not experience an increase in the morbidity and mortality rates when compared to the 2019 rates of the same period [12] . Therefore, it seems that keeping the COVID / no-COVID pathways separate is a safe approach, supported by the fact that the complication rate was overlapping.

All the patients in the waiting list [phone interview] confirmed consent to bariatric surgery, 65 despite the warning on the risk of COVID-19 infection, as well as on the eventual postoperative quarantine.

There is little data on patients with morbid obesity contracting Covid- 19 [13, 14, 15, 16] In Italy on May 4 th , 2020, the so-called "phase 2" has started (virus outbreak under control status Ro <1] ; the phase is characterized by maintaining the strategies adopted to minimize Covid-19 infection [social distancing, respiratory hygiene, face and nose coverings in public settings, school and university closed, ban to all public events] while there is still no specific anti-Covid-19 80 medications and while still waiting for a vaccine.

To delay patients with morbid obesity in the waiting list who are seeking surgery could worsen associated diseases [17, 18] .

. The rapid weight loss after bariatric surgery improves the multiple obesity comorbidities, including obstructive sleep apnea [OSA] [19] . In a self-controlled case series study on a population 85 of 56,277 bariatric surgery patients, the risk of respiratory infection significantly decreased during the first 12 months after surgery [20] .

As a result, we can argue that early intervention on obesity can help minimize the effects of the disease in the event of a second SARS-CoV-2 outbreak. Moreover, obesity not only increases the risk of infection and of complications for the single obese person, but robust evidence indicates 90 that a large obese population increases the chance of more virulent viral strain, prolongs the virus shedding throughout the total community and eventually may increase overall mortality rate of an pandemic [21] .

It seems, therefore, reasonable to address the problem of when and how to re-start the elective bariatric surgery in Italy.

Any resumption of elective bariatric surgery should be prudent and selective, to minimize the risks to patients and healthcare staff [16] . Recently, a panel of experts highlighted the risk of 100 bariatric surgery, especially if out of metabolic control [22] . A prudent re-start should not forget the higher risk in patients over 60 years of age or with type 2 diabetes out of metabolic control [23] . The secondary aim of the paper was to present the proposal of selection criteria for elective obesity surgery in the phase 2 based on Delphi modified process [24] The proposed patient's selection criteria for obesity surgery during phase 2 in Italy follow: The patient should arrive at the hospital 24 -48 hours before hospitalization: outside the hospital, the medical staff must repeat the interview as above and swab the patient. In the case of a positive swab, surgery must be suspended. In the case of negativity, the patient must sign a specific 145 consent, after which the operation can be carried out with hospitalization on the same day of the procedure.

These procedures are in line with international and national guidelines for the screening of patients before entry the hospital [13, 14, 15, 16, 17, 22, 25] Operating Room [OR] protocol 150 The centers participating to the network are committed to following national (Ministry of Health,

Health Authority) and international guidelines recommendations [1, 12, 13, 14, 15, 16, 17, 23, 25] . Moreover, the procedures should be possibly performed by expert surgeons and anesthesiologists to minimize the OR occupation time. 

Italian Ministry of Health

Using mobility to estimate the transmission intensity of COVID-19 in Italy: a subnational analysis with future scenarios

Hospital surge capacity in a tertiary emergency referral centre during the COVID 19 outbreak in Italy

Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis. medRxiv 2020; published online March 30

Case-Fatality Rate and Characteristics of Patients 205

Dying in Relation to COVID-19 in Italy

Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission

Lille Intensive Care COVID-19 and Obesity study group. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 [SARS-CoV-2] requiring invasive mechanical ventilation

Body-mass index and all-cause mortality: 215 individual-participant-data meta-analysis of 239 prospective studies in four continents

Underweight, overweight, and obesity as independent risk factors for hospitalization in adults and children from influenza and other respiratory viruses. Influenza Other Respir Viruses

Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol BMJ 2020

Clinical presentation and initial management 225 critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)infection in Brescia

Covid-19 outbreak and the practice of surgery: do we need to change?

Recommendations for Metabolic and Bariatric Surgery During the COVID-19 Pandemic from IFSO

COVID-19 -ESSKA Guidelines and Recommendations for Resuming Elective Surgery

SAGES and EAES Recommendations for Minimally Invasive Surgery During COVID-19 Pandemic

Obesity Surgery) per la ripresa dell'attività di 240 chirurgia bariatrica e metabolica in elezione durante la fase 2 dell'epidemia Covid 19 in Italia. www.sicob.org

Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery 245

Preventive effect of bariatric surgery on type 2 diabetes onset in morbidly obese in-patients: a national French survey between 2008 and 2016 on 328,509 morbidly obese patients. Surg Obes Relat Dis

How to choose and use Bariatric Surgery in 2015

Association of Bariatric Surgery With Risk of Infectious Diseases: A Self-Controlled Case Series Analysis

Influenza and obesity: its odd relationship and the lessons for COVID 19 pandemic

Endocrine and metabolic link to coronavirus 260 infection

Practical recommendations for the management of diabetes in patients with COVID-19

Consensus development methods, and 265 their use in clinical guideline development

Recommendation to Optimize Safety of Elective Surgical Care While Limiting the Spread of COVID-19: Primum Non Nocere. Arthrosc Sports Med Rehabil